The Institute of Molecular and Cellular Biosciences, the IMCB, at the University of Tokyo began its history as the Institute of Applied Microbiology in 1953. In 1993 the IMCB was reorganized and renamed to its current name to better reflect our objective of making a significant contribution to research in the entire life science disciplines.
The research at the IMCB aims at understanding life processes by elucidating the mechanisms at the cellular, molecular and organism levels.
The IMCB conducts both basic and translational research, translating our findings in basic sciences into the development of new drugs and therapies. Our major areas of interests include drug discovery and regenerative medicine for the treatments of cancer, infectious diseases and cardiovascular diseases.